SCHEMBL20141438

SCHEMBL20141438

O=C(O)N1CCN(c2cccnn2)[C@H](CO)C1

nearest known ligand 0.45

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
MTOR P42345 1/20 0.45
RPTOR Q8N122 1/20 0.45
MLST8 Q9BVC4 1/20 0.45
SLC6A7 Q99884 1/20 0.43
ADAMTS5 Q9UNA0 1/20 0.41
GLS O94925 6/20 0.38
HTR1D P28221 1/20 0.38
TRPV1 Q8NER1 2/20 0.37
DPP4 P27487 1/20 0.36
DPP8 Q6V1X1 1/20 0.36
DPP9 Q86TI2 1/20 0.36
RIPK1 Q13546 1/20 0.35
CHRM4 P08173 1/20 0.35
NAMPT P43490 1/20 0.34
GRM5 P41594 1/20 0.34
RORC P51449 1/20 0.34
MC4R P32245 1/20 0.34
MC3R P41968 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20141307 0.83 GRM1 (0.46) MTORRPTORMLST8SLC6A7
SCHEMBL21360331 0.83 GPR119 (0.43) MTORRPTORMLST8ADAMTS5TRPV1
SCHEMBL20141319 0.80 LMNA (0.45) ADAMTS5
SCHEMBL20141053 0.78 SLC6A7 (0.40) SLC6A7DPP4DPP8DPP9
SCHEMBL20141133 0.77 ADAMTS5 (0.36) MTORRPTORMLST8SLC6A7ADAMTS5
SCHEMBL20141301 0.76 MAPK1 (0.42) ADAMTS5GRM5RORC
SCHEMBL4813898 0.73 SLC6A7 (0.66) SLC6A7TRPV1RIPK1NAMPTGRM5
SCHEMBL21360312 0.72 SLC6A2 (0.40)
SCHEMBL20141224 0.72 KDM4E (0.46)
SCHEMBL21360336 0.72 MTOR (0.83) MTORRPTORMLST8GLS

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20200207716-A1 PHENYL AMINO PIPERIDINE mTORC INHIBITORS AND USES THEREOF NAVITOR PHARMACEUTICALS, INC. 2020-07-02 US disclosed
EP-3538091-A1 PHENYL AMINO PIPERIDINE mTORC INHIBITORS AND USES THEREOF Navitor Pharmaceuticals, Inc. (US) 2019-09-18 EP disclosed
US-10414727-B2 Phenyl amino piperidine mTORC inhibitors and uses thereof NAVITOR PHARMACEUTICALS, INC. (US) 2019-09-17 US disclosed
WO-2018089499-A1 PHENYL AMINO PIPERIDINE mTORC INHIBITORS AND USES THEREOF NAVITOR PHARMACEUTICALS, INC. (US) 2018-05-17 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10414727-B2 Phenyl amino piperidine mTORC inhibitors and uses thereof MTOR, RICTOR, RPTOR MTOR 1/4885RPTOR 3/4885MLST8 7/4885
US-20200207716-A1 PHENYL AMINO PIPERIDINE mTORC INHIBITORS AND USES THEREOF MTOR, RICTOR, RPTOR MTOR 1/4885RPTOR 3/4885MLST8 7/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.